March-in Rights are a common issue discussed within agencies and Congress from time to time. Understand this important issue and why March-in Rights exists by reading more. March-in Rights are a common issue discussed within agencies and Congress from time to time.
Read the U.S. Government Accountability Office's (GAO) July 2009 Report to Congressional Committees, "Information on the Government’s Right to Assert Ownership Control over Federally Funded Inventions." Full report available here.
When Essential Inventions Inc. filed petitions with the NIH in spring 2004 to invoke the march-in provisions of the Bayh-Dole Act to invalidate exclusive drug patents, AUTM mobilized and drafted a letter to the NIH. Read the full text of the letter.
Read AUTM's response to this issue.